Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 43.24 Million | 20.78 Million | 168.24 Million | 40.81 Million | 230.1 Million | 291.41 Million |
| Net Income | -7.64 Million | -290.21 Million | 64.36 Million | 72.83 Million | -395.47 Million | 245.07 Million |
| Depreciation & Amortization | 30.68 Million | 53.81 Million | 46.58 Million | 38.43 Million | 49.87 Million | 43.34 Million |
| Deferred income taxes | - | -168.8 Million | -189.58 Million | -159.46 Million | -75.97 Million | - |
| Stock-based compensation | 12.55 Million | 89.66 Million | 59.35 Million | 23.17 Million | 353 Thousand | 345 Thousand |
| Change in working capital | 15.71 Million | 21.64 Million | -32.45 Million | -59.41 Million | 24.12 Million | 34.49 Million |
| Other non-cash items | 51.04 Million | 314.67 Million | 219.97 Million | 125.25 Million | 627.2 Million | 20.68 Million |
| Investing Cash Flow | 12.08 Million | -118.69 Million | -742.12 Thousand | 10.17 Million | 75.71 Million | 107.35 Million |
| Investments in PPE | -41.79 Million | -88.41 Million | -112.13 Million | -84.14 Million | -85.84 Million | -58.91 Million |
| Acquisitions | 5.74 Million | 161.18 Million | 97.93 Million | 149.24 Million | 19.54 Million | -59.87 Million |
| Investment purchases | -1.43 Billion | -2.5 Billion | -3.09 Billion | -2.74 Billion | -2.84 Billion | -3.27 Billion |
| Sales/Maturities of investments | 1.48 Billion | 2.3 Billion | 3.12 Billion | 2.69 Billion | 3 Billion | 3.49 Billion |
| Other Investing Activities | 5093.02 | 593.05 Thousand | -9.9 Million | -8.84 Million | -18.15 Million | 218.74 Million |
| Financing Cash Flow | -53.15 Million | -173.16 Million | -830.36 Thousand | -104.4 Million | -43.54 Million | -23.13 Million |
| Debt repayment | -2.11 Million | -24.54 Million | -45.38 Million | -105.37 Million | -12.85 Million | -13.17 Million |
| Dividends payments | -42.23 Million | -195.82 Million | -30.35 Million | -209.31 Million | -28.93 Million | -36.3 Million |
| Common Stock Repurchased | -4.78 Million | - | -31.89 Million | - | -1.23 Million | - |
| Common Stock Issuance | - | - | 422.98 Thousand | - | -0.82 | - |
| Other Financing Activities | -1.69 Million | 47.21 Million | 106.37 Million | 210.28 Million | -522.71 Thousand | 21.53 Million |
| Accounts receivables | 37.6 Million | -24.36 Million | -32.25 Million | -39.05 Million | 34.21 Million | -3.07 Million |
| Accounts payables | -28.12 Million | 61.85 Million | 30.25 Million | -10.89 Million | 5.69 Million | 48.64 Million |
| Inventory | 5.33 Million | -8.99 Million | -35.05 Million | -9.46 Million | -15.78 Million | -11.06 Million |
| Other working capital | 902.88 Thousand | -6.85 Million | 4.6 Million | -1.00 | - | - |
| Cash at beginning of period | 555.06 Million | 891.34 Million | 704 Million | 734.62 Million | 482.81 Million | 127.74 Million |
| Cash at end of period | 534.62 Million | 555.06 Million | 891.34 Million | 704 Million | 734.62 Million | 482.81 Million |
| Capital Expenditure | -41.79 Million | -88.41 Million | -112.13 Million | -84.14 Million | -85.84 Million | -58.91 Million |
| Effect of forex changes on cash | - | -0.52 | -0.16 | 1.39 | -0.28 | - |
| Net cash flow / Change in cash | -20.44 Million | -336.27 Million | 187.33 Million | -30.61 Million | 251.8 Million | 355.06 Million |
| Free Cash Flow | 1.45 Million | -67.63 Million | 56.1 Million | -43.33 Million | 144.25 Million | 232.49 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.29 Million | -2.31 Million | -308.05 Thousand | -7.64 Million | -299.47 Thousand | -7.16 Million |
| Depreciation & Amortization | 8.48 Million | 8.53 Million | 7.31 Million | 30.68 Million | 6.13 Million | 17.16 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 2.49 Million | 2.51 Million | 2.06 Million | 89.08 Million | 2.01 Million | 4.11 Million |
| Change in working capital | -4.2 Million | -4.23 Million | 21.79 Million | 15.71 Million | 21.18 Million | -30.72 Million |
| Other non-cash items | -1.96 Million | -1.97 Million | -18.81 Million | 51.04 Million | -17.31 Million | 86.56 Million |
| Investing Cash Flow | 17.42 Million | 17.53 Million | 4.89 Million | 12.08 Million | 4.76 Million | 6.22 Million |
| Investments in PPE | -3.32 Million | -3.34 Million | -3.63 Million | -41.79 Million | -3.53 Million | -22.09 Million |
| Acquisitions | 198.11 Thousand | - | 2.7 Million | 5.74 Million | - | 2.9 Million |
| Investment purchases | -543.1 Million | - | -1.27 Billion | -1.43 Billion | - | -128.86 Million |
| Sales/Maturities of investments | 563.41 Million | - | 1.29 Billion | 1.48 Billion | - | 154.28 Million |
| Other Investing Activities | 20.74 Million | 20.88 Million | 8.52 Million | 5093.02 | 8.29 Million | 12 Million |
| Financing Cash Flow | -4.01 Million | -4.03 Million | -13.81 Million | -53.15 Million | -13.42 Million | -29.6 Million |
| Debt repayment | -1.99 Million | - | -22.18 Million | -2.11 Million | - | -20.04 Million |
| Dividends payments | -110.14 Thousand | -110.86 Thousand | -41.29 Million | -42.23 Million | - | -20.57 Million |
| Common Stock Repurchased | -955.63 Thousand | -961.84 Thousand | 219.1 Thousand | -4.78 Million | - | -4.87 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.94 Million | -2.96 Million | -13.81 Million | -1.69 Million | -13.42 Million | -43.94 Million |
| Accounts receivables | -9.7 Million | -9.77 Million | 18.36 Million | 37.6 Million | 17.85 Million | 735.22 Thousand |
| Accounts payables | -9.28 Million | - | -3.1 Million | -28.12 Million | - | -24.3 Million |
| Inventory | 5.5 Million | 5.53 Million | 3.43 Million | 5.33 Million | 3.33 Million | -1.58 Million |
| Other working capital | 4.91 Million | - | 6.47 Million | 902.88 Thousand | - | -5.57 Million |
| Cash at beginning of period | 534.62 Million | - | 515.82 Million | 555.06 Million | - | 555.06 Million |
| Cash at end of period | 558.53 Million | 16.02 Million | 534.62 Million | 534.62 Million | 3.05 Million | 515.82 Million |
| Capital Expenditure | -3.32 Million | -3.34 Million | -3.63 Million | -41.79 Million | -3.53 Million | -22.09 Million |
| Effect of forex changes on cash | - | - | - | - | - | 0.85 |
| Net cash flow / Change in cash | 23.91 Million | 16.02 Million | 18.79 Million | -20.44 Million | 3.05 Million | -39.24 Million |
| Free Cash Flow | -817.07 Thousand | -822.38 Thousand | 8.42 Million | 1.45 Million | 8.19 Million | -15.74 Million |
AURX
TREAY
EQUITASBNK
SCSC
IOB
LDSN